相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。The oligodendroglial histological features are not independently predictive of patient prognosis in lower-grade gliomas
Eriel Sandika Pareira et al.
BRAIN TUMOR PATHOLOGY (2022)
ISL2 is a putative tumor suppressor whose epigenetic silencing reprograms the metabolism of pancreatic cancer
Harun Ozturk et al.
DEVELOPMENTAL CELL (2022)
Pathomic Fusion: An Integrated Framework for Fusing Histopathology and Genomic Features for Cancer Diagnosis and Prognosis
Richard J. Chen et al.
IEEE TRANSACTIONS ON MEDICAL IMAGING (2022)
FOXM1-mediated NUF2 expression confers temozolomide resistance to human glioma cells by regulating autophagy via the PI3K/AKT/mTOR signaling pathway
Liang Guo et al.
NEUROPATHOLOGY (2022)
CODEL: phase III study of RT, RT plus TMZ, or TMZ for newly diagnosed 1p/19q codeleted oligodendroglioma. Analysis from the initial study design
Kurt A. Jaeckle et al.
NEURO-ONCOLOGY (2021)
Chinese Glioma Genome Atlas (CGGA) : A Comprehensive Resource with Functional Genomic Data from Chinese Glioma Patients
Zheng Zhao et al.
GENOMICS PROTEOMICS & BIOINFORMATICS (2021)
Molecular Features of Glioma Determined and Validated Using Combined TCGA and GTEx Data Analyses
Zijiang Yang et al.
FRONTIERS IN ONCOLOGY (2021)
Clinical Characteristics and Overall Survival Prognostic Nomogram for Oligodendroglioma: A Surveillance, Epidemiology, and End Results Population-Based Analysis
Liang Cao et al.
WORLD NEUROSURGERY (2021)
TROAP regulates cell cycle and promotes tumor progression through Wnt/β-Catenin signaling pathway in glioma cells
Zong-qing Zhao et al.
CNS NEUROSCIENCE & THERAPEUTICS (2021)
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
NEURO-ONCOLOGY (2021)
APLN/APLNR Signaling Controls Key Pathological Parameters of Glioblastoma
Roland E. Kaelin et al.
CANCERS (2021)
ISL2 modulates angiogenesis through transcriptional regulation of ANGPT2 to promote cell proliferation and malignant transformation in oligodendroglioma
Lin Qi et al.
ONCOGENE (2020)
Behavior-Oriented Nomogram for the Stratification of Lower-Grade Gliomas to Improve Individualized Treatment
Ruo-Lun Wei et al.
FRONTIERS IN ONCOLOGY (2020)
LOXL2 Upregulation in Gliomas Drives Tumorigenicity by Activating Autophagy to Promote TMZ Resistance and Trigger EMT
Qing Zhang et al.
FRONTIERS IN ONCOLOGY (2020)
Prognostic factors associated with survival in patients with anaplastic oligodendroglioma
Shuo Liu et al.
PLOS ONE (2019)
A rare form of ion channel gene mutation identified as underlying cause of generalized epilepsy
Till Agnes et al.
ORVOSI HETILAP (2019)
CDKN2A homozygous deletion is a strong adverse prognosis factor in diffuse malignant IDH-mutant gliomas
Romain Appay et al.
NEURO-ONCOLOGY (2019)
Tumor Vessel Normalization, Immunostimulatory Reprogramming, and Improved Survival in Glioblastoma with Combined Inhibition of PD-1, Angiopoietin-2, and VEGF
Mariangela Di Tacchio et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Prognostic relevance of genetic alterations in diffuse lower-grade gliomas
Kosuke Aoki et al.
NEURO-ONCOLOGY (2018)
The role of clinical and molecular factors in low-grade gliomas: what is their impact on survival?
Enrico Franceschi et al.
FUTURE ONCOLOGY (2018)
Prognostic relevance of mutations and copy number alterations assessed with targeted next generation sequencing in IDH mutant grade II glioma
Maarten M. J. Wijnenga et al.
JOURNAL OF NEURO-ONCOLOGY (2018)
IDH1 mutation is associated with a higher preoperative seizure incidence in low-grade glioma: A systematic review and meta-analysis
Yucai Li et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2018)
A radiomic signature as a non-invasive predictor of progression-free survival in patients with lower-grade gliomas
Xing Liu et al.
NEUROIMAGE-CLINICAL (2018)
Multi-faceted computational assessment of risk and progression in oligodendroglioma implicates NOTCH and PI3K pathways
Sameer H. Halani et al.
NPJ PRECISION ONCOLOGY (2018)
Comprehensive RNA-seq transcriptomic profiling in the malignant progression of gliomas
Zheng Zhao et al.
SCIENTIFIC DATA (2017)
A de novo missense mutation in SLC12A5 found in a compound heterozygote patient with epilepsy of infancy with migrating focal seizures
T. Saito et al.
CLINICAL GENETICS (2017)
Biological Significance of Mutant Isocitrate Dehydrogenase 1 and 2 in Gliomagenesis
Shigeo Ohba et al.
NEUROLOGIA MEDICO-CHIRURGICA (2016)
Impaired neuronal KCC2 function by biallelic SLC12A5 mutations in migrating focal seizures and severe developmental delay
Hirotomo Saitsu et al.
SCIENTIFIC REPORTS (2016)
Combined IDH1 mutation and MGMT methylation status on long-term survival of patients with cerebral low-grade glioma
Kazuhiro Tanaka et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2015)
A pilot study using carboplatin, vincristine, and temozolomide in children with progressive/symptomatic low-grade glioma: a Children's Oncology Group study
Murali Chintagumpala et al.
NEURO-ONCOLOGY (2015)
Mutations in SLC12A5 in epilepsy of infancy with migrating focal seizures
Tommy Stodberg et al.
NATURE COMMUNICATIONS (2015)
Localizing seizure-susceptible brain regions associated with low-grade gliomas using voxel-based lesion-symptom mapping
Yinyan Wang et al.
NEURO-ONCOLOGY (2015)
Genetically encoded impairment of neuronal KCC2 cotransporter function in human idiopathic generalized epilepsy
Kristopher T. Kahle et al.
EMBO REPORTS (2014)
A variant of KCC2 from patients with febrile seizures impairs neuronal Cl- extrusion and dendritic spine formation
Martin Puskarjov et al.
EMBO REPORTS (2014)
RNA-seq of 272 gliomas revealed a novel, recurrent PTPRZ1-MET fusion transcript in secondary glioblastomas
Zhao-Shi Bao et al.
GENOME RESEARCH (2014)
Polysomy of chromosomes 1 and 19: an underestimated prognostic factor in oligodendroglial tumors
Haihui Jiang et al.
JOURNAL OF NEURO-ONCOLOGY (2014)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
Prognostic value of isocitrate dehydrogenase 1, O6-methylguanine-DNA methyltransferase promoter methylation, and 1p19q co-deletion in Japanese malignant glioma patients
Yoshinobu Takahashi et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2013)
Survival and long-term health and cognitive outcomes after low-grade glioma
Gregory T. Armstrong et al.
NEURO-ONCOLOGY (2011)
Evaluating sequelae after head and neck cancer from the patient perspective with the help of the International Classification of Functioning, Disability and Health
Uta Tschiesner et al.
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2009)
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Roger Stupp et al.
LANCET ONCOLOGY (2009)
Selection of important variables and determination of functional form for continuous predictors in multivariable model building
Willi Sauerbrei et al.
STATISTICS IN MEDICINE (2007)